CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-03 | Crockett Nigel Chief Business Officer | Sale | −451 | $25.10 | $11K | 29,801 |
| 2023-04-03 | Keen Nicholas Chief Scientific Officer | Sale | −319 | $21.11 | $7K | 38,841 |
| 2023-04-03 | Skynner Michael Chief Technology Officer | Sale | −447 | $21.11 | $9K | 71,375 |
| 2023-04-03 | Milnes Alistair Chief Operating Officer | Sale | −447 | $21.11 | $9K | 37,732 |
| 2023-04-03 | Kalowski Lee President and CFO | Sale | −376 | $21.11 | $8K | 30,309 |
| 2023-04-03 | Crockett Nigel Chief Business Officer | Sale | −447 | $21.11 | $9K | 30,252 |
| 2023-04-03 | Lee Kevin Chief Executive Officer | Sale | −1,486 | $21.11 | $31K | 325,099 |
| 2023-03-31 | Arroyo Santiago Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2023-01-03 | Jordan Veronica GH Director | Grant or award | +5,750 | 10,750 | ||
| 2023-01-03 | Jordan Veronica GH Director | Grant or award · Stock Option (right to buy) | +11,500 | 11,500 | ||
| 2023-01-03 | Winter Gregory Paul Director | Grant or award | +5,750 | 174,677 | ||
| 2023-01-03 | Winter Gregory Paul Director | Grant or award · Stock Option (right to buy) | +11,500 | 11,500 | ||
| 2023-01-03 | Crockett Nigel Chief Business Officer | Grant or award | +17,500 | 32,500 | ||
| 2023-01-03 | Crockett Nigel Chief Business Officer | Sale | −1,801 | $29.06 | $52K | 30,699 |
| 2023-01-03 | Crockett Nigel Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-03 | Milnes Alistair Chief Operating Officer | Grant or award | +17,500 | 39,980 | ||
| 2023-01-03 | Milnes Alistair Chief Operating Officer | Sale | −1,801 | $29.06 | $52K | 38,179 |
| 2023-01-03 | Milnes Alistair Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-03 | Smethurst Dominic Chief Medical Officer | Grant or award | +17,500 | 38,500 | ||
| 2023-01-03 | Smethurst Dominic Chief Medical Officer | Sale | −1,801 | $29.06 | $52K | 36,699 |
Page 15 of 26 · 520 trades